HOUSTON (Diya TV) — Indian-origin cancer researcher Raghuraman Kannan of the University of Missouri has been elected a 2025 Fellow of the National Academy of Inventors (NAI), a top honor that recognizes inventors whose work delivers real-world impact. The university announced the selection this week, placing Kannan among the most influential academic inventors in the United States.
The recognition highlights the growing role of scientists of Indian origin in American research and innovation. It also underscores the rising importance of cancer-focused technologies with global health value.
The National Academy of Inventors elects Fellows for inventions that improve the quality of life, drive economic growth, and benefit society. The academy evaluates measurable impact, not just research output. NAI Fellows often translate lab discoveries into products, therapies, and tools used around the world.
Kannan joins the 2025 class of NAI Fellows, which includes innovators from universities, government agencies, and research institutions across the United States. The academy said the new class represents 127 institutions across 40 states and holds more than 5,300 U.S. patents.
Kannan serves as a Curators’ Distinguished Professor at the University of Missouri. He also holds the Michael J. and Sharon R. Bukstein Chair in Cancer Research. He maintains joint appointments at the university’s School of Medicine and College of Engineering. He also acts as associate director of the Immuno-oncology and Therapeutics Program at the Ellis Fischel Cancer Center.
His work focuses on improving how doctors deliver cancer drugs. Kannan developed a large library of nanoparticle-based drug delivery platforms. These systems target cancer tumors more precisely. They also reduce harm to healthy tissue. This approach aims to improve treatment outcomes while limiting side effects. His research supports new therapies for lung, ovarian, breast, pancreatic, and liver cancers. These cancers affect millions of patients worldwide.
Kannan holds 65 issued patents, including 12 active U.S. patents. His inventions move beyond theory. They support drug development and clinical research. They also help bridge the gap between engineering and medicine. The University of Missouri said his work reflects a strong commitment to innovation with patient impact. His technologies aim to make cancer treatment safer and more effective.
“Being named an NAI Fellow is a profound honor,” Kannan said in a statement released by the university. He credited his colleagues, collaborators, and students for the achievement.
Kannan is one of two University of Missouri professors named to the 2025 NAI Fellows class. The other inductee is Henry Nguyen, a professor of plant genetics at the same university. Nguyen is known for his work in plant genetics and biotechnology. His research focuses on improving crop resilience through genomic tools. His work supports global food security efforts. He holds five issued patents, including one active U.S. patent.
The dual recognition reflects the university’s strength in both health sciences and agricultural innovation. Kannan’s election adds to a growing list of Indian-origin researchers earning top honors in the United States. Their work spans medicine, engineering, agriculture, and technology. Many focus on problems with global relevance, such as cancer care and food security.
